Publications by authors named "Lyndon Kim"

33 Publications

Targeted systemic therapies for primary brain tumors.

Authors:
Lyndon Kim

Chin Clin Oncol 2020 Dec;9(6):73

Division of Neuro-Oncology, Department of Neurology, Medicine and Neurosurgery, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article and Find Full Text PDF
December 2020

A narrative review of targeted therapies in meningioma.

Authors:
Lyndon Kim

Chin Clin Oncol 2020 Dec 17;9(6):76. Epub 2020 Dec 17.

Division of Neuro-Oncology, Department of Neurology, Medicine and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

View Article and Find Full Text PDF
December 2020

Outcomes after stereotactic radiosurgery for CNS lymphoma.

J Neurooncol 2020 Apr 27;147(2):465-476. Epub 2020 Feb 27.

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, USA.

View Article and Find Full Text PDF
April 2020

Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.

Radiother Oncol 2019 03 4;132:135-141. Epub 2019 Jan 4.

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, United States. Electronic address:

View Article and Find Full Text PDF
March 2019

Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?

J Neurooncol 2018 Dec 4;140(3):623-628. Epub 2018 Sep 4.

Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.

View Article and Find Full Text PDF
December 2018

Rethinking medulloblastoma from a targeted therapeutics perspective.

J Neurooncol 2018 Sep 5;139(3):713-720. Epub 2018 Jun 5.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
September 2018

Ependymomas overexpress chemoresistance and DNA repair-related proteins.

Oncotarget 2018 Jan 15;9(8):7822-7831. Epub 2017 Dec 15.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
January 2018

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.

J Neurooncol 2016 May 29;127(3):535-9. Epub 2016 Jan 29.

Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, 111 South 11th Street, Philadelphia, PA, 19107, USA.

View Article and Find Full Text PDF
May 2016

Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

J Neurooncol 2015 Sep 30;124(2):215-21. Epub 2015 May 30.

Department of Radiation Oncology, Sidney Kimmel Cancer Center and Sidney Kimmel Medical College at Thomas Jefferson University, Bodine Center for Cancer Treatment, 111 South 11th Street, Philadelphia, PA, 19107, USA.

View Article and Find Full Text PDF
September 2015

A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).

J Neurooncol 2014 Jun 17;118(2):335-343. Epub 2014 Apr 17.

Hematology/Oncology Section, Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH, 03756, USA.

View Article and Find Full Text PDF
June 2014

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme.

J Neurooncol 2014 Mar 19;117(1):125-31. Epub 2014 Jan 19.

Department of Radiation Oncology, University of Pittsburgh Cancer Institute, UPMC CancerCenter at UPMC St. Margaret, 200 Delafield Road, Pittsburgh, PA, 15215, USA,

View Article and Find Full Text PDF
March 2014

Chemoirradiation for glioblastoma multiforme: the national cancer institute experience.

PLoS One 2013 5;8(8):e70745. Epub 2013 Aug 5.

Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.

View Article and Find Full Text PDF
March 2014

Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging.

Cancer 2011 Oct 28;117(19):4506-11. Epub 2011 Mar 28.

Department of Neurological Surgery, University of California at Irvine Medical Center, Orange, California, USA.

View Article and Find Full Text PDF
October 2011

A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas.

Neuro Oncol 2010 Feb 22;12(2):181-9. Epub 2010 Jan 22.

Neuro-Oncology Branch, National Cancer Institute, NIH, 9030 Old Georgetown Road, Bloch Bldg. 82, room 225, Bethesda, MD 20892, USA.

View Article and Find Full Text PDF
February 2010

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.

Cancer 2010 Apr;116(7):1776-82

Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article and Find Full Text PDF
April 2010

A phase I trial of enzastaurin in patients with recurrent gliomas.

Clin Cancer Res 2009 May 5;15(10):3617-23. Epub 2009 May 5.

Neuro-Oncology Branch and Biometric Research Branch, National Cancer Institute, National Institute of Neurological Disorder and Stroke, NIH, Bethesda, MD 20892, USA.

View Article and Find Full Text PDF
May 2009